NIH-funded research R01 grant

Understanding how certain brain cells control hunger

Official title: Feedforward Activation of AgRP Neurons and Hunger

Funded at Beth Israel Deaconess Medical Center · NIH-11134422 · Data updated 2026-11-12

This study is looking at how certain brain cells that control hunger respond to different signals, like food smells or sights, and it’s for anyone interested in understanding more about appetite and finding new ways to manage weight.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 4, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$509,395
NIH project number5R01DK134427-03
Project IDNIH-11134422 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals struggling with obesity or appetite regulation.

Less likely to help

Patients with eating disorders unrelated to hunger regulation may not benefit from this research.

What this research studies

This research investigates the role of AgRP neurons in regulating hunger and how their activity is influenced by various signals. Traditionally, it was believed that these neurons were primarily controlled by feedback from the body's energy stores, such as leptin and insulin levels. However, recent findings suggest that sensory cues related to food can also rapidly activate these neurons, independent of energy balance. By monitoring AgRP neuron activity in real-time, the research aims to uncover new mechanisms that trigger hunger responses, potentially leading to innovative approaches for managing appetite and obesity.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for controlling hunger and managing weight-related issues.

How similar studies have gone: While the investigation of feedforward activation of AgRP neurons is relatively novel, previous studies have successfully explored feedback mechanisms in appetite regulation.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Lowell, Bradford B — Beth Israel Deaconess Medical Center
  • Study coordinator: Lowell, Bradford B

Related research

Other NIH-funded projects on the same topics.

  • SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers

    This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625633

  • Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study

    This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625632

  • Statin use after brain bleed: SATURN MRI ancillary study

    This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625628

  • XenCAT: Single Cell Atlas for Xenopus

    Aims to map gene activity at the single-cell level in Xenopus to help understand how cells develop and how this relates to human disease.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11594482

  • Statin use after lobar intracerebral hemorrhage

    This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518526

  • Statin use after lobar brain hemorrhage

    This trial compares stopping versus continuing statin medicine in people who had a lobar brain bleed to learn effects on repeat bleeding and future heart or stroke events.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518525

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.